Jack Nielsen
Président chez Biopharma Holding ApS
Fortune : - $ au 30/06/2024
Profil
Mr. Jack B.
Nielsen is a Managing Partner at Vivo Capital LLC and a Chairman at Biopharma Holding ApS.
He is on the Board of Directors at Ocelot Bio, Inc., ALX Oncology Ltd., Harmony Biosciences LLC and Vivo Co-Invest (S) LP.
Mr. Nielsen was previously employed as an Independent Director by IO Biotech, Inc., an Independent Director by Instil Bio, Inc., an Independent Director by ALX Oncology Holdings, Inc., a Lead Independent Director by Aligos Therapeutics, Inc., an Independent Director by Harmony Biosciences Holdings, Inc., an Independent Director by Crinetics Pharmaceuticals, Inc., a Member-Supervisory Board by Merus NV, an Independent Director by Akebia Therapeutics, Inc., a Chairman by Alios BioPharma, Inc., an Independent Director by ProteinSimple, an Independent Director by Reata Pharmaceuticals, Inc., a Partner by Novo Ventures (US), Inc., a Senior Partner by Novo Holdings A/S (Investment Company), a Senior Partner by Novo Ventures 1 A/S, a Senior Partner by Novo Nordisk A/S, and a Senior Partner by Novo Holdings AS (Denmark).
He also served on the board at MacuLogix, Inc., Procept Corp, Kanyos Bio, Inc., Unchained Labs LLC (California), Anokion SA, Apollo Endosurgery, Inc., MediQuest Therapeutics, Inc., Apollo Endosurgery, Inc. /Old/, Cardio-Optics, Inc., Neomend, Inc., Nuevolution AB, Panacos Pharmaceuticals, Inc., Protein Forest, Inc., Rainier Therapeutics, Inc. and Tobira Therapeutics, Inc. /Old/.
He received his graduate degree from Technical University of Denmark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 | |
| 31/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 | |
INSTIL BIO, INC.
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
| 29/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 | |
IO BIOTECH, INC.
-.--% | 08/04/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Jack Nielsen
| Sociétés | Poste | Début |
|---|---|---|
Biopharma Holding ApS
 Biopharma Holding ApS Financial ConglomeratesFinance Biopharma Holding ApS functions as a financial holding Danish company. The private company is based in Copenhagen, Denmark. | Président | - |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Directeur/Membre du Conseil | 01/02/2020 |
| Vivo Co-Invest (S) LP | Directeur/Membre du Conseil | - |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Directeur/Membre du Conseil | 01/09/2017 |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01/08/2017 |
Ocelot Bio, Inc.
 Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on improving outcomes for patients with end-stage liver disease (ESLD), particularly those suffering from hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. The company is based in San Diego, CA. The company is developing therapeutic peptides to treat complications of decompensated cirrhosis, a condition in which the liver is scarred and permanently damaged, leading to liver failure. HRS-AKI is a life-threatening consequence of portal hypertension, which causes a significant drop in arterial pressure and renal perfusion. Ocelot Bio is in early-stage development of OCE-205 for the treatment of ascites, a complication of ESLD-induced portal hypertension that leads to the accumulation of fluid in the peritoneal cavity. The company was founded by Geoffrey Harris, and Katherine Vega Stultz has been the CEO of the company since 2022. | Directeur/Membre du Conseil | 01/04/2021 |
Anciens postes connus de Jack Nielsen
| Sociétés | Poste | Fin |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 27/06/2024 |
| ALIGOS THERAPEUTICS, INC. | Président | - |
| ALX ONCOLOGY HOLDINGS INC. | Directeur/Membre du Conseil | 28/04/2024 |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jack Nielsen
| Technical University of Denmark | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 10 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| PROCEPT BIOROBOTICS CORPORATION | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| MERUS N.V. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| IO BIOTECH, INC. | Health Technology |
| Entreprise privées | 27 |
|---|---|
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
MediQuest Therapeutics, Inc.
 MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Apollo Endosurgery, Inc. /Old/
 Apollo Endosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Apollo Endosurgery, Inc. provides medical devices for treatment of obesity. It offers OverStitch, an endoscopic suturing system that enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope; and LAP-BAND, an adjustable gastric banding system for weight loss goals. The company was founded by Sergey Kantsevoy, Anthony Kalloo, Robert Hawes, Christopher J. Gostout and Dennis L. McWilliams in 2006 and is headquartered in Austin, TX. | Health Technology |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Health Technology |
Protein Forest, Inc.
 Protein Forest, Inc. Packaged SoftwareTechnology Services Protein Forest, Inc., a privately held company founded in 2002 and is located in Lexington, MA, is a developer and manufacturer of state-of-the-art sample fractionation technology, products, and data analysis software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world. | Technology Services |
Cardio-Optics, Inc.
 Cardio-Optics, Inc. Medical SpecialtiesHealth Technology Cardio-Optics, Inc. develops medical devices. It develops catheter systems to treat cardiovascular disease inside the heart and great vessels. The firm's core proprietary technology is catheter based infrared (IR) transmission and image processing to image though blood. The company was founded by John Hanlin and David Amundson in 1998 and is headquartered in Wilmington, MA. | Health Technology |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Health Technology |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services MacuLogix, Inc. engages in the early detection and tracking of retinal diseases. Its AdaptDx is the first practical measurement tool for dark adaptation which provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma. The company also provides macular degeneration services. The company was founded by John G. Edwards and Gregory R. Jackson in 2004 and is headquartered in Harrisburg, PA. | Health Services |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Finance |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Health Technology |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Health Technology |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Health Technology |
Apollo Endosurgery, Inc.
 Apollo Endosurgery, Inc. Medical SpecialtiesHealth Technology Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX. | Health Technology |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
| Aligos Therapeutics, Inc. | |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on improving outcomes for patients with end-stage liver disease (ESLD), particularly those suffering from hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. The company is based in San Diego, CA. The company is developing therapeutic peptides to treat complications of decompensated cirrhosis, a condition in which the liver is scarred and permanently damaged, leading to liver failure. HRS-AKI is a life-threatening consequence of portal hypertension, which causes a significant drop in arterial pressure and renal perfusion. Ocelot Bio is in early-stage development of OCE-205 for the treatment of ascites, a complication of ESLD-induced portal hypertension that leads to the accumulation of fluid in the peritoneal cavity. The company was founded by Geoffrey Harris, and Katherine Vega Stultz has been the CEO of the company since 2022. | Health Technology |
| Vivo Co-Invest (S) LP | |
Biopharma Holding ApS
Biopharma Holding ApS Financial ConglomeratesFinance Biopharma Holding ApS functions as a financial holding Danish company. The private company is based in Copenhagen, Denmark. | Finance |
